- Home
- ASIX vs SAGE Comparison
ASIX vs SAGE Comparison
Compare ASIX & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIX
- SAGE
- Stock Information
- Founded
- ASIX 2016
- SAGE 2010
- Country
- ASIX United States
- SAGE United States
- Employees
- ASIX N/A
- SAGE N/A
- Industry
- ASIX Major Chemicals
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- ASIX Industrials
- SAGE Health Care
- Exchange
- ASIX Nasdaq
- SAGE Nasdaq
- Market Cap
- ASIX 654.2M
- SAGE 571.1M
- IPO Year
- ASIX N/A
- SAGE 2014
- Fundamental
- Price
- ASIX $23.12
- SAGE $9.14
- Analyst Decision
- ASIX Buy
- SAGE Hold
- Analyst Count
- ASIX 1
- SAGE 18
- Target Price
- ASIX $32.00
- SAGE $9.89
- AVG Volume (30 Days)
- ASIX 178.4K
- SAGE 3.4M
- Earning Date
- ASIX 08-01-2025
- SAGE 07-30-2025
- Dividend Yield
- ASIX 2.77%
- SAGE N/A
- EPS Growth
- ASIX 3682.26
- SAGE N/A
- EPS
- ASIX 3.11
- SAGE N/A
- Revenue
- ASIX $1,558,519,000.00
- SAGE $47,404,000.00
- Revenue This Year
- ASIX $7.41
- SAGE $102.21
- Revenue Next Year
- ASIX $4.60
- SAGE $43.01
- P/E Ratio
- ASIX $7.44
- SAGE N/A
- Revenue Growth
- ASIX 6.03
- SAGE N/A
- 52 Week Low
- ASIX $18.44
- SAGE $4.62
- 52 Week High
- ASIX $33.00
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- ASIX 41.76
- SAGE 70.89
- Support Level
- ASIX $22.62
- SAGE $9.13
- Resistance Level
- ASIX $25.53
- SAGE $9.36
- Average True Range (ATR)
- ASIX 0.68
- SAGE 0.12
- MACD
- ASIX -0.17
- SAGE -0.06
- Stochastic Oscillator
- ASIX 17.18
- SAGE 54.69
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.